200 related articles for article (PubMed ID: 24118704)
1. Age-dependent decline of β-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study.
Barker A; Lauria A; Schloot N; Hosszufalusi N; Ludvigsson J; Mathieu C; Mauricio D; Nordwall M; Van der Schueren B; Mandrup-Poulsen T; Scherbaum WA; Weets I; Gorus FK; Wareham N; Leslie RD; Pozzilli P
Diabetes Obes Metab; 2014 Mar; 16(3):262-7. PubMed ID: 24118704
[TBL] [Abstract][Full Text] [Related]
2. Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA1c, and Insulin Dose.
Hao W; Gitelman S; DiMeglio LA; Boulware D; Greenbaum CJ;
Diabetes Care; 2016 Oct; 39(10):1664-70. PubMed ID: 27422577
[TBL] [Abstract][Full Text] [Related]
3. Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis.
Mortensen HB; Swift PG; Holl RW; Hougaard P; Hansen L; Bjoerndalen H; de Beaufort CE; Knip M;
Pediatr Diabetes; 2010 Jun; 11(4):218-26. PubMed ID: 19708904
[TBL] [Abstract][Full Text] [Related]
4. Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes.
Picardi A; Visalli N; Lauria A; Suraci C; Buzzetti R; Merola MK; Manfrini S; Guglielmi C; Gentilucci UV; Pitocco D; Crinò A; Bizzarri C; Cappa M; Pozzilli P
Horm Metab Res; 2006 Oct; 38(10):668-72. PubMed ID: 17075776
[TBL] [Abstract][Full Text] [Related]
5. BMI is an important driver of β-cell loss in type 1 diabetes upon diagnosis in 10 to 18-year-old children.
Lauria A; Barker A; Schloot N; Hosszufalusi N; Ludvigsson J; Mathieu C; Mauricio D; Nordwall M; Van der Schueren B; Mandrup-Poulsen T; Scherbaum WA; Weets I; Gorus FK; Wareham N; Leslie RD; Pozzilli P
Eur J Endocrinol; 2015 Feb; 172(2):107-13. PubMed ID: 25378371
[TBL] [Abstract][Full Text] [Related]
6. Proinsulin to C-Peptide Ratio in the First Year After Diagnosis of Type 1 Diabetes.
Freese J; Al-Rawi R; Choat H; Martin A; Lunsford A; Tse H; Mick G; McCormick K
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4318-e4326. PubMed ID: 34228132
[TBL] [Abstract][Full Text] [Related]
7. Clinical and metabolic characteristics of patients with latent autoimmune diabetes in adults (LADA): absence of rapid beta-cell loss in patients with tight metabolic control.
Chaillous L; Bouhanick B; Kerlan V; Mathieu E; Lecomte P; Ducluzeau PH; Delamaire M; Sonnet E; Maugendre D; Maréchaud R; Rohmer V; Saï P; Charbonnel B
Diabetes Metab; 2010 Feb; 36(1):64-70. PubMed ID: 20060765
[TBL] [Abstract][Full Text] [Related]
8. A randomized placebo-controlled trial of alphacalcidol on the preservation of beta cell function in children with recent onset type 1 diabetes.
Ataie-Jafari A; Loke SC; Rahmat AB; Larijani B; Abbasi F; Leow MK; Yassin Z
Clin Nutr; 2013 Dec; 32(6):911-7. PubMed ID: 23395257
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of nicotinamide and vitamin E in children with recent onset type 1 diabetes (IMDIAB IX).
Crinò A; Schiaffini R; Manfrini S; Mesturino C; Visalli N; Beretta Anguissola G; Suraci C; Pitocco D; Spera S; Corbi S; Matteoli MC; Patera IP; Manca Bitti ML; Bizzarri C; Pozzilli P;
Eur J Endocrinol; 2004 May; 150(5):719-24. PubMed ID: 15132730
[TBL] [Abstract][Full Text] [Related]
10. Residual
Lin K; Yang X; Wu Y; Chen S; Zeng Q
J Diabetes Res; 2021; 2021():9946874. PubMed ID: 34258294
[TBL] [Abstract][Full Text] [Related]
11. Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study.
Dabelea D; Mayer-Davis EJ; Andrews JS; Dolan LM; Pihoker C; Hamman RF; Greenbaum C; Marcovina S; Fujimoto W; Linder B; Imperatore G; D'Agostino R
Diabetologia; 2012 Dec; 55(12):3359-68. PubMed ID: 22990715
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA).
Li X; Liao L; Yan X; Huang G; Lin J; Lei M; Wang X; Zhou Z
Diabetes Metab Res Rev; 2009 Jul; 25(5):411-6. PubMed ID: 19488999
[TBL] [Abstract][Full Text] [Related]
13. A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitus.
Crinó A; Schiaffini R; Ciampalini P; Suraci MC; Manfrini S; Visalli N; Matteoli MC; Patera P; Buzzetti R; Guglielmi C; Spera S; Costanza F; Fioriti E; Pitocco D; Pozzilli P;
J Pediatr Endocrinol Metab; 2005 Aug; 18(8):749-54. PubMed ID: 16200840
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone combined with insulin preserves islet beta cell function in adult-onset latent autoimmune diabetes (LADA).
Zhou Z; Li X; Huang G; Peng J; Yang L; Yan X; Wang J
Diabetes Metab Res Rev; 2005; 21(2):203-8. PubMed ID: 15386806
[TBL] [Abstract][Full Text] [Related]
15. The PTPN22 1858T gene variant in type 1 diabetes is associated with reduced residual beta-cell function and worse metabolic control.
Petrone A; Spoletini M; Zampetti S; Capizzi M; Zavarella S; Osborn J; Pozzilli P; Buzzetti R;
Diabetes Care; 2008 Jun; 31(6):1214-8. PubMed ID: 18252906
[TBL] [Abstract][Full Text] [Related]
16. No effect of the altered peptide ligand NBI-6024 on beta-cell residual function and insulin needs in new-onset type 1 diabetes.
Walter M; Philotheou A; Bonnici F; Ziegler AG; Jimenez R;
Diabetes Care; 2009 Nov; 32(11):2036-40. PubMed ID: 19690081
[TBL] [Abstract][Full Text] [Related]
17. Effect of heat shock protein peptide DiaPep277 on beta-cell function in paediatric and adult patients with recent-onset diabetes mellitus type 1: two prospective, randomized, double-blind phase II trials.
Schloot NC; Meierhoff G; Lengyel C; Vándorfi G; Takács J; Pánczél P; Barkai L; Madácsy L; Oroszlán T; Kovács P; Sütö G; Battelino T; Hosszufalusi N; Jermendy G
Diabetes Metab Res Rev; 2007 May; 23(4):276-85. PubMed ID: 17103487
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestations and beta cell function in Swedish diabetic children have remained unchanged during the last 25 years.
Nordwall M; Ludvigsson J
Diabetes Metab Res Rev; 2008 Sep; 24(6):472-9. PubMed ID: 18613248
[TBL] [Abstract][Full Text] [Related]
19. C-peptide response and HLA genotypes in subjects with recent-onset type 1 diabetes after immunotherapy with DiaPep277: an exploratory study.
Buzzetti R; Cernea S; Petrone A; Capizzi M; Spoletini M; Zampetti S; Guglielmi C; Venditti C; Pozzilli P;
Diabetes; 2011 Nov; 60(11):3067-72. PubMed ID: 21896927
[TBL] [Abstract][Full Text] [Related]
20. Insulin secretion measured by stimulated C-peptide in long-established Type 1 diabetes in the Diabetes Control and Complications Trial (DCCT)/ Epidemiology of Diabetes Interventions and Complications (EDIC) cohort: a pilot study.
McGee P; Steffes M; Nowicki M; Bayless M; Gubitosi-Klug R; Cleary P; Lachin J; Palmer J;
Diabet Med; 2014 Oct; 31(10):1264-8. PubMed ID: 24836354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
